ClinicalTrials.Veeva

Menu

Level of Serum Lactate Dehydrogenase in Immune Thrombocytopenia

S

Sohag University

Status

Not yet enrolling

Conditions

Immune Thrombocytopenia (ITP)

Treatments

Diagnostic Test: Lactate dehydrogenase

Study type

Observational

Funder types

Other

Identifiers

NCT07046013
Soh-Med-25-5-7MS

Details and patient eligibility

About

Assessment of relation between serum lactate dehydrogenase and immune thrombocytopenia

Full description

Immune thrombocytopenia is an autoimmune disorder defined by a significantly reduced number of platelets in blood circulation.

Lactate dehydrogenase is a group of oxidoreductase isoenzymes catalyzing the reversible reaction between pyruvate and lactate.

The LDH was found to be moderately high in patients with immune thrombocytopenia at the time of diagnosis.

Enrollment

40 estimated patients

Sex

All

Ages

16+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Thrombocytopenia patients at the time of diagnosis.

Exclusion criteria

  • bone fractures _ bone diseases_ malignancy

Trial contacts and locations

0

Loading...

Central trial contact

Hassnaa Ahmed Abo elwafa, Prof.Dr; Shaimaa Mahmoud Fahmy, Resident doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems